Vacina da dengue do Butantan: 26 pessoas tiveram reações leve em Montes Claros, diz Prefeitura
Governo anuncia paralisação da vacinação contra a dengue Em Montes Claros, 26 pessoas, das 680 que receberam a vacina contra a dengue do Instituto Butantan, apresentaram reações consideradas leves. O Ministério da Saúde anunciou, nessa segunda-feira (8), a suspensão do uso do imunizante após o registro de duas mortes suspeitas. 🔎Segundo o Ministério da Saúde, foram aplicadas 500 mil doses até o dia 30 de maio. Nesse universo, houve 42 casos de reações adversas severas, com si
The Brazilian Ministry of Health has temporarily suspended the use of the Butantan dengue vaccine following reports of two suspected deaths and 42 severe adverse reactions nationwide. In Montes Claros, 26 out of 680 individuals who received the vaccine experienced mild side effects like skin rashes and muscle pain, with no severe cases reported in the city. The vaccine, developed by the Butantan Institute, is the world's first single-dose dengue vaccine and the first fully Brazilian one. The Ministry emphasized that the suspension is a precautionary measure for reassessment and that vaccination with the Takeda Qdenga vaccine for adolescents continues as scheduled.
The suspension of the Butantan dengue vaccine is significant because it impacts public health efforts to control dengue fever and raises questions about the safety and rollout of novel vaccines.
📌 Kaynak
Bu özet Globo G1 (BR) kaynağından otomatik derlenmiştir. Tamamı için orijinal habere gidin.
Orijinal haberi oku →